why choose us

First received: December 05, 2022

Clinical Trial: Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia

Study Type: INTERVENTIONAL


Official Title: Effect of Early Initiation of Evolocumab and Combination Lipid-lowering Agent on Lipid Profiles Changes in Patients With Acute Coronary Syndrome Undergoing percuTAneous coronaRy Intervention: a Prospe

Brief Summary: Investigators aimed to evaluate efficacy and safety of early Initiation of evolocumab and combination lipid-lowering agent (statin + Ezetimibe) on lipid profiles changes in patients with ACS undergoing PCI

Read more